Publication:
Treatment failure of gentamicin in pediatric patients with oropharyngeal tularemia

Simple item page
dc.contributor.authorKAYA, ALİ
dc.contributor.authorUYSAL, İSMAİL ÖNDER
dc.contributor.authorGÜVEN, AHMET SAMİ
dc.contributor.authorENGİN, AYNUR
dc.contributor.authorGÜLTÜRK, ABDULAZİZ
dc.contributor.authorİÇAĞASIOĞLU, FÜSUN DİLARA
dc.contributor.authorCevit, Omer
dc.contributor.institutionauthorİÇAĞASIOĞLU, DİLARA FÜSUN
dc.date.accessioned2020-10-29T22:40:03Z
dc.date.available2020-10-29T22:40:03Z
dc.date.issued2011-07-01T00:00:00Z
dc.description.abstractBackground: Tularemia is a zoonotic infection, and the causative agent is Francisella tularensis. A first-line therapy for treating tularemia is aminoglycosides (streptomycin or, more commonly, gentamicin), and treatment duration is typically 7 to 10 days, with longer courses for more severe cases.
dc.identifier.citationKAYA A., UYSAL İ. Ö. , GÜVEN A. S. , ENGİN A., GÜLTÜRK A., İÇAĞASIOĞLU F. D. , Cevit O., -Treatment failure of gentamicin in pediatric patients with oropharyngeal tularemia-, MEDICAL SCIENCE MONITOR, cilt.17, 2011
dc.identifier.doi10.12659/msm.881848
dc.identifier.scopus79960000751
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26676
dc.identifier.wosWOS:000293140200008
dc.titleTreatment failure of gentamicin in pediatric patients with oropharyngeal tularemia
dc.typeArticle
dspace.entity.typePublication
local.avesis.idbac86664-9ae4-495e-8bb1-79996eaf75e4
local.publication.isinternational1
relation.isAuthorOfPublicationd6e0d341-df58-438f-bfac-96639f63d5d3
relation.isAuthorOfPublication.latestForDiscoveryd6e0d341-df58-438f-bfac-96639f63d5d3
Files
Collections
Silinecekler